Literature DB >> 16940475

Calcitonin forms oligomeric pore-like structures in lipid membranes.

Marco Diociaiuti1, Laura Zanetti Polzi, Luisa Valvo, Fiorella Malchiodi-Albedi, Cecilia Bombelli, Maria Cristina Gaudiano.   

Abstract

Calcitonin is a polypeptidic hormone involved in calcium metabolism in the bone. It belongs to the amyloid protein family, which is characterized by the common propensity to aggregate acquiring a beta-sheet conformation and include proteins associated with important neurodegenerative diseases. Here we show for the first time, to our knowledge, by transmission electron microscopy (TEM) that salmon-calcitonin (sCT) forms annular oligomers similar to those observed for beta-amyloid and alpha-sinuclein (Alzheimer's and Parkinson's diseases). We also investigated the interaction between sCT and model membranes, such as liposomes, with particular attention to the effect induced by lipid "rafts" made of cholesterol and G(M1). We observed, by TEM immunogold labeling of sCT, that protein binding is favored by the presence of rafts. In addition, we found by TEM that sCT oligomers inserted in the membrane have the characteristic pore-like morphology of the amyloid proteins. Circular dichroism experiments revealed an increase in beta-content in sCT secondary structure when the protein was reconstituted in rafts mimicking liposomes. Finally, we showed, by spectrofluorimetry experiments, that the presence of sCT allowed Ca(2+) entry in rafts mimicking liposomes loaded with the Ca(2+)-specific fluorophore Fluo-4. This demonstrates that sCT oligomers have ion-channel activity. Our results are in good agreement with recent electrophysiological studies reporting that sCT forms Ca(2+)-permeable ion channels in planar model membranes. It has been proposed that, beyond the well-known interaction of the monomer with the specific receptor, the formation of Ca(2+) channels due to sCT oligomers could represent an extra source of Ca(2+) entry in osteoblasts. Structural and functional data reported here support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940475      PMCID: PMC1557561          DOI: 10.1529/biophysj.105.079475

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  29 in total

1.  In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis.

Authors:  W Blaine Stine; Karie N Dahlgren; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

2.  P-glycoprotein inserted in planar lipid bilayers formed by liposomes opened on amorphous carbon and Langmuir-Blodgett monolayer.

Authors:  Marco Diociaiuti; Agnese Molinari; Irene Ruspantini; Maria Cristina Gaudiano; Rodolfo Ippoliti; Eugenio Lendaro; Federico Bordi; Pietro Chistolini; Giuseppe Arancia
Journal:  Biochim Biophys Acta       Date:  2002-02-10

Review 3.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

4.  Channel formation by salmon and human calcitonin in black lipid membranes.

Authors:  V Stipani; E Gallucci; S Micelli; V Picciarelli; R Benz
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

5.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-04-09       Impact factor: 3.162

6.  Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Katsuhiko Yanagisawa; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

7.  Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid.

Authors:  A Kakio; S I Nishimoto; K Yanagisawa; Y Kozutsumi; K Matsuzaki
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

Review 8.  Ion channel formation and membrane-linked pathologies of misfolded hydrophobic proteins: the role of dangerous unchaperoned molecules.

Authors:  Joseph I Kourie; Christine L Henry
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-09       Impact factor: 2.557

9.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  14 in total

Review 1.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

2.  Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy.

Authors:  Ravi Prakash Reddy Nanga; Jeffrey R Brender; Jiadi Xu; Kevin Hartman; Vivekanandan Subramanian; Ayyalusamy Ramamoorthy
Journal:  J Am Chem Soc       Date:  2009-06-17       Impact factor: 15.419

3.  How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin.

Authors:  Kirsten Gade Malmos; Morten Bjerring; Christian Moestrup Jessen; Erik Holm Toustrup Nielsen; Ebbe T Poulsen; Gunna Christiansen; Thomas Vosegaard; Troels Skrydstrup; Jan J Enghild; Jan Skov Pedersen; Daniel E Otzen
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

Review 4.  Half a century of amyloids: past, present and future.

Authors:  Pu Chun Ke; Ruhong Zhou; Louise C Serpell; Roland Riek; Tuomas P J Knowles; Hilal A Lashuel; Ehud Gazit; Ian W Hamley; Thomas P Davis; Marcus Fändrich; Daniel Erik Otzen; Matthew R Chapman; Christopher M Dobson; David S Eisenberg; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2020-07-07       Impact factor: 54.564

5.  Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein.

Authors:  Masahiro Kawahara; Isao Ohtsuka; Shoko Yokoyama; Midori Kato-Negishi; Yutaka Sadakane
Journal:  Int J Alzheimers Dis       Date:  2011-04-12

6.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08

Review 7.  The slowly aggregating salmon Calcitonin: a useful tool for the study of the amyloid oligomers structure and activity.

Authors:  Marco Diociaiuti; Maria Cristina Gaudiano; Fiorella Malchiodi-Albedi
Journal:  Int J Mol Sci       Date:  2011-12-13       Impact factor: 5.923

8.  Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation.

Authors:  Richard Lantz; Brian Busbee; Ewa P Wojcikiewicz; Deguo Du
Journal:  Biopolymers       Date:  2019-12-05       Impact factor: 2.240

9.  Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils.

Authors:  Ricardo H Pires; Árpád Karsai; Maria J Saraiva; Ana M Damas; Miklós S Z Kellermayer
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes.

Authors:  Daniela Meleleo; Enrico Gallucci; Vittorio Picciarelli; Silvia Micelli
Journal:  Eur Biophys J       Date:  2007-03-29       Impact factor: 2.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.